57 filings
Page 2 of 3
8-K
qhc yf3uhzz
27 Apr 23
Other Events
9:12am
8-K
lgre awgr57gq748y
27 Apr 23
Regulation FD Disclosure
8:40am
8-K
j96d r7696gl
21 Apr 23
Investment proceeds expected to fund planned operations of the combined company into mid-2024
5:14pm
8-K
waqnrp9sj1k
20 Apr 23
Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Split
7:38pm
8-K
6d176dwm
12 Apr 23
Vallon Pharmaceuticals Adjourns Special Meeting of Stockholders Until
4:06pm
8-K
l6zlrsu i5nsl
7 Apr 23
Other Events
8:24am
8-K
bt6y uk7hd
4 Apr 23
Other Events
9:01am
8-K
2dda5x mh
31 Mar 23
Other Events
4:35pm
8-K
qtcs52 tpex9
2 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
l0nq24gdctfz d30
24 Feb 23
Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results
7:34am
8-K
f2sv 9qbfx9cxttqib
11 Jan 23
Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event
8:30am
8-K
ldj2tomb6famz1dao0f
29 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
1pse 2qg8nk4
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
n1z7cqznudp5 m9
3 Nov 22
Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:32pm
8-K
zu4g6b
28 Jul 22
Vallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:04am
8-K
bfvw v9brbgab4t8r9e4
26 Jul 22
Entry into a Material Definitive Agreement
4:12pm
8-K
bhesl473y 3m6644
13 Jul 22
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
fi5j05rr
28 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
t23p02rdep7yf3 rhtn
10 Jun 22
Submission of Matters to a Vote of Security Holders
8:30am
8-K
1gbse1uk16q76x 20zcv
18 May 22
Unregistered Sales of Equity Securities
5:07pm